2 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow 10-valent pneumococcal vaccine: new trials by email Literature Review of 10-valent pneumococcal vaccine trials Research Report on 10-valent pneumococcal vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate vaccine, DTaP-IPV-HB-Hib vaccine - Meningococcal Infections | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1660 | 2018-12-14 | 2025-03-03 |
| Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age GSK2202083A vaccine, 10-valent pneumococcal vaccine (GSK 1024850A), Infanrix hexa™ - Tetanus, Diphtheria | Phase 2 | Completed | GlaxoSmithKline | 421 | 2009-08-13 | 2020-01-03 |
Diphtheria (1) · Haemophilus Infections (1) · Hepatitis B (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Poliomyelitis (1) · Tetanus (1)
GlaxoSmithKline (1) · Sanofi Pasteur, a Sanofi Company (1)
Poland (2) · Czechia (1) · Finland (1) · Italy (1) · Romania (1) · Spain (1) · Sweden (1)
2009 (1), 2017 (1)